Expired Canadian patentCanada
Compounds inhibiting the binding of sap for treating osteoarthritis
CA 2528706 C · Owner: Pepys, Mark B. · Inventors: Pepys, Mark B.; Hawkins, Philip Nigel
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Use of an agent capable of inhibiting serum amyloid P component (SAP) ligand binding activity or depleting SAP from the plasma of a subject for the production of a medicament for treatment or prevention of osteoarthritis in the subject.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 10, 2004 and granted October 30, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 10, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 10, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 10, 2004
GrantedOctober 30, 2012
Term endedJune 10, 2024
Patent numberCA 2528706 C
Classification (IPC)A61K31/40 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.